GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75N91023C00053OPTOSURGICAL, LLC

Overview

Award facts

Net obligations
$3.50M
$3,500,000of $3.50M potential value
Outlays (paid to date)
$3.50M
$3.50M paid of $3.50M obligated$3,500,000
Period of performance
Sep 15, 2023 to Dec 19, 2025
Ended
Modifications
5
Latest action Feb 3, 2026
Contract type
Definitive contract
PIID 75N91023C00053

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

ARPA-H SBIR PHASE II TOPIC 4 FOR INTRA-OPERATIVE CONTRAST AGENTS

Dates and value

Award date
Signed on Sep 15, 2023
Potential end of performance
Dec 18, 2025
Current value
$3,500,000Base and exercised options
Potential value (if all options are exercised)
$3,500,000

Obligations by fiscal year of action

  • FY2023: $3,500,000

Total across 1 fiscal year: $3,500,000

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Feb 3, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationCOLUMBIA, MD
UEIN5FFBMLQHAJ9
CAGE code8BQW2
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyOPTOSURGICAL, LLC

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Funded from
Advanced research projects agency for health (0837)Program activities075-0837Federal accounts (agency financial reports)

Place of performance

Place of performance
Columbia, Howard County, Maryland 21046-3138
Congressional district (place of performance)
MD-03As reported at the time of the action

Classification and competition

Classification

Product or service (PSC)
AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (research and development)

Competition

Extent competed
Full and open competition after exclusion of sourcesD
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Small business set aside - totalSBA
Contract pricing
Firm fixed priceJ
Offers received
2

Solicitation and notices

Solicitation ID
75N91023R00041
Solicitation date
Jun 2, 2023
Notices

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
Yes
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Sep 15, 2023Base obligation at award: $3,500,000
Latest action
Feb 3, 2026 — CloseoutModification P00005; administrative: no change in scope or value
Latest substantive action
Sep 12, 2025 — Supplemental agreement (within scope)Modification P00004
Actions by type
  • Base award1
  • Other administrative action2
  • Supplemental agreement (within scope)1
  • Closeout1
  • Transfer between offices1
6 actions recorded, Sep 15, 2023 to Feb 3, 2026; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Research program (SBIR/STTR)
Small business innovation research program phase ii actionSR2

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N992
Transactions recorded under this award key
6

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N992
Treasury accounts
  • 075-2022/2024-0837-000
Object classes
  • 25.2: Other services from non-Federal sources
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression